The stock of Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) last traded at $4.24, up 4.69% from the previous session.
IRWD stock price is now -33.36% away from the 50-day moving average and -54.11% away from the 200-day moving average. The market capitalization of the company currently stands at $677.30M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target reduced from $12 to $4, CapitalOne Downgraded its rating from Overweight to Equal Weight for Ironwood Pharmaceuticals Inc (NASDAQ: IRWD). On January 17, 2024, Craig Hallum recently initiated its ‘Buy’ rating on the stock quoting a target price of $21, while ‘Wells Fargo’ rates the stock as ‘Overweight’
In other news, John Minardo, Officer bought 11,726 shares of the company’s stock on Aug 12 ’24. The stock was bought for $47,490 at an average price of $4.05. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 10 ’24, Director McHugh Julie sold 22,766 shares of the business’s stock. A total of $143,198 was realized by selling the stock at an average price of $6.29. This leaves the insider owning 139,528 shares of the company worth $0.59 million. A total of 2.62% of the company’s stock is owned by insiders.
During the past 12 months, Ironwood Pharmaceuticals Inc has had a low of $3.79 and a high of $15.70. The fifty day moving average price for IRWD is $6.3272 and a two-hundred day moving average price translates $9.21565 for the stock.
The latest earnings results from Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) was released for 2024-06-30. The net profit margin was 2.30% and return on equity was -559.14% for IRWD. The company reported revenue of $94.4 million for the quarter, compared to $107.38 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -12.09 percent.
